By proceeding, you agree to our Terms of Use and Privacy Policy.
CEO
#development #cellcycleregulation #epigenetics
#EastAsia
Dr. Blanchard most recently served as chief scientific officer at a subsidiary of Innovent Biologics, Inc. (HKEX: 1801), from January 2018 to June 2019.